Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Nanomedicine. 2012 Oct 3;9(3):419–427. doi: 10.1016/j.nano.2012.09.003

Figure 4.

Figure 4

IL-6 Production in Cartilage Plugs when dosed with 50μg nanoparticles loaded with KAFAK. Plots A–E represents aggrecan depleted plugs dosed with IL-1β. Plot F represents plugs with intact aggrecan and no IL-1β stimulation. Plots are normalized to individual plug weight and IL-6 production from the negative control and represent average ± SEM (N=4). *P<.05 or 0.05<+P<0.10 with respect to IL-1β only treatment